Sarepta Therapeutics, a U.S. commercial-stage biopharma company focused on unique RNA-targeted therapeutics for the treatment of rare neuromuscular diseases, has opened its Research and Manufacturing Center in Andover, MA. The 60,000-sq.-ft. facility significantly enhances its research and manufacturing capabilities, expands its global commercial footprint, and advances its Duchenne muscular dystrophy (DMD) pipeline, which comprises an exon skipping platform and next generation approaches suc...